BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 36558782)

  • 1. Genome Analysis and Antibiofilm Activity of Phage 590B against Multidrug-Resistant and Extensively Drug-Resistant Uropathogenic
    Chaudhary N; Maurya RK; Singh D; Mohan B; Taneja N
    Pathogens; 2022 Nov; 11(12):. PubMed ID: 36558782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization, genome analysis and in vitro activity of a novel phage vB_EcoA_RDN8.1 active against multi-drug resistant and extensively drug-resistant biofilm-forming uropathogenic Escherichia coli isolates, India.
    Chaudhary N; Mohan B; Mavuduru RS; Kumar Y; Taneja N
    J Appl Microbiol; 2022 Apr; 132(4):3387-3404. PubMed ID: 34989075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole genome sequencing and
    Chaudhary N; Singh D; Maurya RK; Mohan B; Mavuduru RS; Taneja N
    Data Brief; 2022 Aug; 43():108479. PubMed ID: 35924093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. |Isolation and characterization of novel bacteriophages as a potential therapeutic option for Escherichia coli urinary tract infections.
    González-Villalobos E; Ribas-Aparicio RM; Montealegre GER; Belmont-Monroy L; Ortega-García Y; Aparicio-Ozores G; Balcázar JL; Eslava-Campos CA; Hernández-Chiñas U; Molina-López J
    Appl Microbiol Biotechnol; 2021 Jul; 105(13):5617-5629. PubMed ID: 34254156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and in vitro activity of a lytic phage RDN37 isolated from community sewage water active against MDR Uropathogenic E. coli.
    Chaudhary N; Narayan C; Mohan B; Taneja N
    Indian J Med Microbiol; 2021 Jul; 39(3):343-348. PubMed ID: 33994226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complete Genome Sequence of Escherichia Phage 590B, Active against an Extensively Drug-Resistant Uropathogenic Escherichia coli Isolate.
    Chaudhary N; Singh D; Narayan C; Samui B; Mohan B; Mavuduru RS; Taneja N
    Microbiol Resour Announc; 2021 Sep; 10(38):e0055021. PubMed ID: 34554004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and Characterization of Novel Lytic Phages Infecting Multidrug-Resistant Escherichia coli.
    Vera-Mansilla J; Sánchez P; Silva-Valenzuela CA; Molina-Quiroz RC
    Microbiol Spectr; 2022 Feb; 10(1):e0167821. PubMed ID: 35171030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic characterization of two bacteriophages (vB_EcoS-phiEc3 and vB_EcoS-phiEc4) belonging to the genus Kagunavirus with lytic activity against uropathogenic Escherichia coli.
    Rodea GE; González-Villalobos E; Medina-Contreras O; Castelán-Sánchez HG; Aguilar-Rodea P; Velázquez-Guadarrama N; Hernández-Chiñas U; Eslava-Campos CA; Balcázar JL; Molina-López J
    Microb Pathog; 2022 Apr; 165():105494. PubMed ID: 35314281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phage Resistance Accompanies Reduced Fitness of Uropathogenic Escherichia coli in the Urinary Environment.
    Zulk JJ; Clark JR; Ottinger S; Ballard MB; Mejia ME; Mercado-Evans V; Heckmann ER; Sanchez BC; Trautner BW; Maresso AW; Patras KA
    mSphere; 2022 Aug; 7(4):e0034522. PubMed ID: 35920561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and synergy studies of Caudoviricete Escherichia phage FS2B infecting multi-drug resistant uropathogenic Escherichia coli isolates.
    Malik S; Nehra K; Mann A; Jagdish R; Rana JS
    Int Microbiol; 2024 Feb; 27(1):155-166. PubMed ID: 37247084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel bacteriophage vB_EcoP-EG1 with lytic activity against planktonic and biofilm forms of uropathogenic Escherichia coli.
    Gu Y; Xu Y; Xu J; Yu X; Huang X; Liu G; Liu X
    Appl Microbiol Biotechnol; 2019 Jan; 103(1):315-326. PubMed ID: 30397766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Phage Cocktail To Control Surface Colonization by Proteus mirabilis in Catheter-Associated Urinary Tract Infections.
    Mirzaei A; Wagemans J; Nasr Esfahani B; Lavigne R; Moghim S
    Microbiol Spectr; 2022 Oct; 10(5):e0209222. PubMed ID: 36194151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacteriophages with the ability to degrade uropathogenic Escherichia coli biofilms.
    Chibeu A; Lingohr EJ; Masson L; Manges A; Harel J; Ackermann HW; Kropinski AM; Boerlin P
    Viruses; 2012 Apr; 4(4):471-87. PubMed ID: 22590682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacteriophage cocktail and phage antibiotic synergism as promising alternatives to conventional antibiotics for the control of multi-drug-resistant uropathogenic Escherichia coli.
    Malik S; Nehra K; Rana JS
    Virus Res; 2021 Sep; 302():198496. PubMed ID: 34182014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biofilm formation, antimicrobial susceptibility and virulence genes of Uropathogenic Escherichia coli isolated from clinical isolates in Uganda.
    Katongole P; Nalubega F; Florence NC; Asiimwe B; Andia I
    BMC Infect Dis; 2020 Jun; 20(1):453. PubMed ID: 32600258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of bacteriophages infecting multidrug-resistant uropathogenic Escherichia coli strains.
    Markusková B; Elnwrani S; Andrezál M; Sedláčková T; Szemes T; Slobodníková L; Kajsik M; Drahovská H
    Arch Virol; 2024 Jun; 169(7):142. PubMed ID: 38851653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and Evaluation of Bacteriophage Cocktail to Eradicate Biofilms Formed by an Extensively Drug-Resistant (XDR)
    Vashisth M; Jaglan AB; Yashveer S; Sharma P; Bardajatya P; Virmani N; Bera BC; Vaid RK; Anand T
    Viruses; 2023 Feb; 15(2):. PubMed ID: 36851640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-Wide Discovery of Genes Required for Capsule Production by Uropathogenic
    Goh KGK; Phan MD; Forde BM; Chong TM; Yin WF; Chan KG; Ulett GC; Sweet MJ; Beatson SA; Schembri MA
    mBio; 2017 Oct; 8(5):. PubMed ID: 29066548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of effectiveness for phage cocktail development against multiple Salmonella serovars and its biofilm control activity.
    Ribeiro JM; Pereira GN; Durli Junior I; Teixeira GM; Bertozzi MM; Verri WA; Kobayashi RKT; Nakazato G
    Sci Rep; 2023 Aug; 13(1):13054. PubMed ID: 37567926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacteriophage therapy for
    Bhargava K; Nath G; Dhameja N; Kumar R; Aseri GK; Jain N
    Future Microbiol; 2023 Apr; 18():323-334. PubMed ID: 37140267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.